Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 492 results for "edelweiss securities"

15 stocks to watch out for
Sify

Edelweiss Financial Services secures rating for proposed debt ...

Corporate News Published on Fri Sep 05, 2014 at 08:26 PM Edelweiss Financial Services announced that CRISIL vide its letter dated 05 September 2014 has assigned `CRISIL A1+` (CRISIL A one plus) to the Company`s proposed Short Term Debt Issue ... HDFC Securities, 1 week ago
Realty trusts build base on prop Calcutta Telegraph, 1 month ago

3 images for "edelweiss securities"

Rediff.com, 1 month ago
Rediff.com, 2 months ago
Rediff.com, 2 months ago
Business Today India

No pre-Budget correction, stay invested: Edelweiss

Atul Badkar of Edelweiss Securities lists out his recommended stocks. In an interview with CNBC-TV18, he advises investors to go long in stocks as no major correction may be witnessed before the Budget.
 Money Control2 months ago Overseas investors lineup to invest in top-rated corporate bonds  Economic Times2 weeks ago Kuwait SWF among anchor investors in Sharda Cropchem; IPO subscribed...  VC Circle1 week ago Ten bargain stocks you must invest in right now  Business Today India3 weeks ago

HSBC, IDFC, Edelweiss to manage NHPC stake sale

The disinvestment department today shortlisted three merchant bankers, including HSBC Securities, for managing the 11.36 per cent stake sale in NHPC, that could fetch over Rs 2,600 crore to the exchequer. Edelweiss Financial, IDFC Capital and HSBC Securities ...
 Business Standard2 weeks ago HSBC IDFC Edelweiss to manage NHPC stake sale  Big News Network2 weeks ago NHPC : EIGHT iBANKS IN THE RACE TO MANAGE NHPC ISSUE  4 Traders3 weeks ago 8 merchant bankers, including ICICI Securities, SBI Capital bid for NHPC's stake sale  Economic Times1 month ago
[x]  

Prefer Tata Motors: Atul Badkar

Atul Badkar Of Edelweiss Securities prefers Tata Motors from the automobile space.
 Money Control2 months ago Expect Biocon to test Rs 580: Atul Badkar  Money Control2 months ago

Kotak, Edelweiss best bet among brokerage companies: Mehraboon Irani

In a chat with ET Now, Mehraboon Irani, Principal & Head-Private Client Group Business, Nirmal Bang Securities, shares his views on brokerage companies. Excerpts: ET Now: Is the brokerage business something that you like because Edelweiss has done ...
 Economic Times1 month ago

Media`s Q1FY15 revenue may grow by 11.2% YoY: Edelweiss

Edelweiss Securities has come out with its report on Media universe. The research firm expects Q1FY15 revenue of media universe to grow 11.2% YoY, though EBITDA and PAT are likely to decline by 2.3% and 23% YoY respectively, says the report.
 Money Control2 months ago

ONGC could see earnings upgrade if subsidy burden falls in FY15

Company's profits may increase by 25% with under-recoveries coming down further, says Edelweiss Securities
 Business Standard2 months ago

Reforms in agri sector by Govt will be crucial for sector: Vikas Khemani, Edelweiss Securities

In a chat with ET Now,Vikas Khemani, CEO, Edelweiss Securities, talks about their 'Agri Day' conference. Excerpts: ET Now: Tell us a little bit more about Edelweiss Agri Day. What is the theme of the conference going to be and why this subject really? Vikas ...
 Economic Times2 months ago Reforms in agriculture by Govt will be crucial for the sector: Vikas Khemani, Edelweiss Securities  Economic Times2 months ago

Oil reforms would be low on agenda for upcoming budget 2014: Edelweiss Sec

Edelweiss Securities believes significant oil reforms would be low on agenda for the upcoming Union Budget 2014 in turn disappointing markets. ''To avert a concentrated and immediate impact on inflation of a high 331bps, we feel the government will stagger ...
 Myiris2 months ago

Edelweiss Sec reiterates `Buy` on Dr Reddy`s Lab

Edelweiss Securities has reiterated 'Buy' on Dr Reddy's Laboratories with target price of Rs 3,300 as against current market price (CMP) of Rs 2,463 in its report. Commenting on the investment rationale, the stock broker said, ''Zemplar (paricalcitol, oral ...
 Myiris2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less